News and Information Related to Women's Health Issues. Learn about hormones, birth control, pregnancy, menopause, breast exams and much more.
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

FDA Approves Emergency Contraceptive

Called 'ella,' drug delays ovulation, but opponents say it's another abortion pill

FRIDAY, Aug. 13 (HealthDay News) -- The U.S. Food and Drug Administration on Friday approved the ella (ulipristal acetate) emergency contraceptive pill, which prevents pregnancy if taken within five days of unprotected intercourse or contraceptive failure.

The prescription-only drug, which has been available in Europe since May 2009, is a progesterone agonist/antagonist that is thought to work by inhibiting or delaying ovulation, according to a statement from the FDA.

Advertisement
Related Stories
 border=
Patient Disparities Seen in Lung Cancer Drug Trials
Satisfaction With Life Seems Good for the Heart
U.S. Database of Breast Cancer Treatment May Be Inaccurate
Related Videos
 border=
Baby Steps: Fertility Findings
Tumor Detecting App: Medicine's Next Big Thing?
Powerful Combo Reducing Lymphedema
Related Slides
 border=
Pelvic Inflam Disease
Placenta Abruptio
PMS
Related Encyclopedia
 border=
Amenorrhea
Amniocentesis
Amniocentesis and CVS


Approval comes after an agency advisory committee unanimously supported ella's approval in a decision announced in June.

"The safety and efficacy of ella were demonstrated in two phase [3] clinical trials," the FDA noted. "One study was a prospective, multi-center, open-label, single-arm trial conducted in the United States; the other was a randomized, multi-center, single-blind comparator-controlled trial conducted in the United States, United Kingdom and Ireland."

The agency said that side effects noted with ella are similar to those of other emergency contraceptives already approved and include headache, abdominal pain, nausea, pain/discomfort during menstruation (dysmenorrhea), fatigue and dizziness. The drug, manufactured by Paris-based Laboratoire HRA Pharma, is not recommended for women who are pregnant or think they might be pregnant or for women who are breast-feeding.

Planned Parenthood was quick to commend the FDA's decision.

"Every woman deserves every option available to prevent an unplanned pregnancy, and there are many reasons why a woman may face the risk of unintended pregnancy, from failure or improper use of birth control to sexual assault," Cecile Richards, the group's president, said in a statement. "The FDA's approval of this new form of emergency contraception gives women one more option."

But ella has its detractors, as well. Experts believe the drug works by delaying the ability of the ovaries to produce an egg. However, opponents note that progesterone is also required to help the womb prepare for an already fertilized egg -- raising the possibility that the drug works similarly to RU-486, which prevents a fertilized egg from implantation in the womb.

"Ella is an abortion drug," Wendy Wright, president of Concerned Women for America, told the Washington Post. "It operates the same way as RU-486 -- the abortion drug. Many women may be comfortable taking a contraceptive but would object to taking an abortion drug."

But ella's proponents dismiss those charges, saying that there's no data to support the notion that the drug works as anything but a contraceptive.

More information

For a look at ella's labeling, head to the FDA.

-- E.J. Mundell

SOURCES: Aug. 13, 2010, news release, U.S. Food and Drug Administration; statement, Planned Parenthood Federation of America; Washington Post

Copyright © 2010 HealthDay. All rights reserved.
Last updated 8/14/2010



Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.


Feb 5, 2012
Home
Search
Powered By HealthLine
New! For timely and trustworth health information, expert advice and much more, visit Breast Cancer Connection
Patient Guide
News
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Newsletters
Privacy Policy
Terms of Use

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service  

To find more information on specific conditions, please visit our partner sites: